UNSPSC 85891402: Hyperthermia of bone marrow

This classification denotes the group of activities that yields a radiation therapy intervention or procedure of hyperthermia of bone marrow. This intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code D7Y08ZZ

UNSPSC 85891402 Hyperthermia of bone marrow is a Commodity code showing minimal alignment with recent state and local procurement activity. The code nominally describes a medical treatment modality, but the recent opportunities posted under this classification span a diverse, unrelated range of healthcare services including virtual urgent care, occupational health screening, cancer registry support, psychiatric evaluation, EMS billing, medical directorships, wellness programs, and opioid treatment initiatives. No posted solicitations directly address bone marrow hyperthermia or closely related oncologic or hematologic treatments, indicating either a classification mismatch in the source data or extremely limited procurement activity under this narrow Commodity code.

The issuing bodies across the recent opportunities include state health authorities (Nevada, Colorado, New Jersey, Texas, Illinois), county health systems and behavioral health departments (Santa Clara, San Mateo, Ventura, Sedgwick, Fairfax, Cobb, DeKalb, Brevard, Boulder, Jackson, Rockland), municipal fire and EMS agencies (Atlanta, Sarasota, Phoenix, Seminole), independent school districts (Parkway), and cooperative purchasing consortiums (Sourcewell, H-GAC). Activity is geographically dispersed across California, Colorado, Georgia, Kansas, New Jersey, Nevada, Oregon, Texas, Florida, and other states, with no concentration in any particular region. Without substantive recent opportunities directly related to bone marrow hyperthermia services, business development professionals should treat this code as inactive for state and local procurement purposes and monitor higher-tier medical treatment and oncology service codes for more actionable market signals.